User:Mr. Ibrahem/Azacitidine

Azacitidine, sold under the brand name Vidaza among others, is a medication used to treat myelodysplastic syndrome, acute myeloid leukaemia (AML), chronic myelomonocytic leukaemia. It is given by injection into a vein or under the skin.

Common side effects include nausea, low red blood cells, low platelets, fever, low white blood cells, diarrhea, low potassium, and bruises. Other side effects may include liver problems, kidney problems, and tumor lysis syndrome. Use in pregnancy may harm the baby. It is a cytosine analogue which works by blocking DNA methylation.

Azacitidine was approved for medical use in the United States in 2004 and Europe in 2008. It is available as a generic medication. In the United Kingdom 100 mg costs the NHS about £220 as of 2021. In the United States this amount costs about 83 USD.